Page last updated: 2024-08-17

cytidine monophosphate and Diarrhea

cytidine monophosphate has been researched along with Diarrhea in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, CH; Chen, CM; Chiou, MT; Chuang, CK; Hsiao, KH; Hung, SW; Peng, SH; Su, YH; Tu, CF; Yang, TS; Yen, CH	1
Braess, J; Freund, M; Hanauske, A; Heil, G; Hiddemann, W; Kaufmann, C; Kern, W; Schleyer, E; Schüssler, M	1
Fukuoka, M; Hattori, M; Hirota, Y; Miyazaki, T; Nakamura, T; Niitani, H; Ohta, K; Suzuoki, Y; Tanaka, M; Yoshida, Y	1

Trials

2 trial(s) available for cytidine monophosphate and Diarrhea

Article	Year
Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics. Leukemia, 1998, Volume: 12, Issue:10 Topics: Acute Disease; Administration, Oral; Adult; Antineoplastic Agents; Arabinonucleotides; Biological Availability; Cytarabine; Cytidine Monophosphate; Diarrhea; Dose-Response Relationship, Drug; Half-Life; Humans; Infusions, Intravenous; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Prodrugs; Regression Analysis	1998
[Phase I study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:11 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Diarrhea; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Middle Aged; Myelodysplastic Syndromes; Nausea; Vomiting	1990

Article

Year

Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics.

Leukemia, 1998, Volume: 12, Issue:10

Topics: Acute Disease; Administration, Oral; Adult; Antineoplastic Agents; Arabinonucleotides; Biological Availability; Cytarabine; Cytidine Monophosphate; Diarrhea; Dose-Response Relationship, Drug; Half-Life; Humans; Infusions, Intravenous; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Prodrugs; Regression Analysis

1998

[Phase I study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate)].

Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:11

Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Diarrhea; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Middle Aged; Myelodysplastic Syndromes; Nausea; Vomiting

1990

Other Studies

1 other study(ies) available for cytidine monophosphate and Diarrhea

Article	Year
Lessening of porcine epidemic diarrhoea virus susceptibility in piglets after editing of the CMP-N-glycolylneuraminic acid hydroxylase gene with CRISPR/Cas9 to nullify N-glycolylneuraminic acid expression. PloS one, 2019, Volume: 14, Issue:5 Topics: Animals; Coronavirus Infections; CRISPR-Cas Systems; Cytidine Monophosphate; Diarrhea; Disease Susceptibility; Enterocytes; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Neuraminic Acids; Porcine epidemic diarrhea virus; Pregnancy; Swine; Swine Diseases	2019

Article

Year

Lessening of porcine epidemic diarrhoea virus susceptibility in piglets after editing of the CMP-N-glycolylneuraminic acid hydroxylase gene with CRISPR/Cas9 to nullify N-glycolylneuraminic acid expression.

PloS one, 2019, Volume: 14, Issue:5

Topics: Animals; Coronavirus Infections; CRISPR-Cas Systems; Cytidine Monophosphate; Diarrhea; Disease Susceptibility; Enterocytes; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Neuraminic Acids; Porcine epidemic diarrhea virus; Pregnancy; Swine; Swine Diseases

2019